Recombinant Bacillus subtilis GlcNAc Production via Metabolic Flux Redirection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing N-acetylglucosamine (GlcNAc) via microbial fermentation in engineered Bacillus subtilis result in low GlcNAc titer and yield due to inefficient glucose conversion, limiting its industrial application.
Innovation Solution
A method involving the deletion of phosphoenolpyruvate carboxykinase (pckA) and pyruvate kinase (pyk) genes, combined with the overexpression of pyruvate carboxylase (pycA), is employed to enhance GlcNAc production in recombinant Bacillus subtilis, optimizing glucose utilization and metabolic pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the phosphotransferase system (PTS) is used for glucose uptake in B. subtilis, then efficient glucose transport is achieved, but excessive glucose is consumed to synthesize pyruvate, resulting in low GlcNAc titer and low conversion yield
Solution Approach 1:
The invention extracts and removes the harmful metabolic pathway by deleting the pyk gene (pyruvate kinase) and pckA gene (phosphoenolpyruvate carboxykinase), which are responsible for excessive pyruvate synthesis. This eliminates the metabolic route that causes glucose waste while preserving the beneficial PTS glucose transport system.
Solution Approach 2:
The invention changes the metabolic parameters by overexpressing the pyc gene (pyruvate carboxylase) to alter the flux distribution in central metabolism. This gene overexpression redirects metabolic flow away from the harmful pyruvate synthesis pathway toward GlcNAc production, optimizing the conversion efficiency of glucose to GlcNAc.
2Reliability
If conventional metabolic pathways are maintained in engineered B. subtilis, then basic cellular functions are preserved, but GlcNAc titer remains low, limiting industrial application
Solution Approach 1:
The invention segments the metabolic network into functional modules by selectively deleting specific genes (pyk, pckA) while preserving others. This modular approach allows independent optimization of GlcNAc production pathways without compromising essential cellular functions, achieving both reliability and high productivity.
Solution Approach 2:
Instead of trying to enhance GlcNAc production by adding more enzymes to existing pathways, the invention inverts the approach by removing enzymes that create competing pathways and metabolic drains. This subtraction strategy redirects metabolic flux more effectively than addition alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases GlcNAc production, with a 1.84-fold improvement to 11.3 g/L, enhancing the yield and productivity of GlcNAc, making it suitable for industrial production.
Implementation Method 1
Biological production of GlcNAc via microbial fermentation by engineered B. subtilis emerged as a promising method to produce GlcNAc in a safe and sustainable approach
Data Source
AI summary
The invention provides an effective method for improving N-acetylglucosamine (GlcNAc) production by engineered B. subtilis Deletion of phosphoenolpyruvate carboxykinase encoding gene pckA and encoding pyruvate kinase gene pyK in recombinant GlcNAc-producing strain BSGNK-PxylA-glmS-P43-GNA1 (BSGNK) is first performed to enhance GlcNAc production, followed by overexpression of pyruvate carboxylase encoding gene pycA for facilitating cell growth. Finally, the GlcNAc production of the recombinant strain BPTS3 reached to 11.3 g/L, which was 1.84-fold of BSGNK. This method can be used for improve cellular property of engineered B. subtilis for GlcNAc production, which can be further applied to industrial production of GlcNAc.